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Edited by Pascale CossartAbstract Clostridial binary toxins, such as Clostridium perfrin-
gens Iota and Clostridium botulinum C2, are composed of a
binding protein (Ib and C2-II, respectively) that recognizes
distinct membrane receptors and mediates internalization of a
catalytic protein (Ia and C2-I, respectively) with ADP-ribosyl-
transferase activity that depolymerizes the actin cytoskeleton.
After internalization, it was found that C2 and Iota toxins were
not routed to the Golgi apparatus and exhibited diﬀerential sen-
sitivity to inhibitors of endosome acidiﬁcation. While the C2-I
component of C2 toxin was translocated into the cytosol from
early endosomes, translocation of the Ia component of Iota toxin
occurred between early and late endosomes, was dependent on
more acidic conditions, and uniquely required a membrane poten-
tial gradient.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Clostridial binary toxins are actin-modifying, ADP-ribosy-
lating proteins produced by several Clostridium species and
divided into two families. The Iota-family encompasses Iota
toxin from Clostridium perfringens type E, Clostridium spiro-
forme toxin and Clostridium diﬃcile ADP-ribosyltransferase.
C2 toxin is produced by Clostridium botulinum types C as well
as D, and is the sole representative of the C2-family. The clos-
tridial binary toxins share a common structure, consisting of
two independent proteins corresponding to the enzymatic
and binding components. The binding component (Ib for Iota
toxin and C2-II for C2 toxin) is synthesized as a nontoxic pre-
cursor (100 and 80 kDa, respectively) that is proteolytically
activated into the mature form (80 and 60 kDa, respectively)
after removal of a 20 kDa N-terminal peptide. These binding
components recognize distinct, yet unidentiﬁed, cell-surface
receptors and mediate cytosolic internalization of the corre-*Corresponding author. Fax: +33 1 40 61 31 23.
E-mail address: mpopoﬀ@pasteur.fr (M.R. Popoﬀ).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.02.041sponding enzymatic component. In contrast to the enzymatic
component of C2 toxin (C2-I), that of Iota toxin (Ia) requires
proteolytic activation via cleavage of 9 to 13 N-terminal amino
acids [1]. Ia catalyzes the mono ADP-ribosylation of globular
actin from muscle and non-muscle types at residue R177,
whereas C2-I activity is restricted to non-muscular actin
[2,3]. These toxins are responsible for a complete disorganiza-
tion of actin ﬁlaments and cell rounding. Toxin components of
the Iota-family are immunologically related and can be inter-
changed to form biologically-active, hybrid toxins. Thereby,
Ib can internalize the enzymatic components from either C.
spiroforme or C. diﬃcile toxin. In contrast, C2 toxin which is
structurally and functionally related to the Iota-family of tox-
ins, does not immunologically cross react or associate with
Iota-family components to reconstitute a biologically func-
tional toxin [4,5].
Many toxins are active only at the intracellular level, and cell
entry is therefore the ﬁrst critical step for intoxication. Once in-
side a cell, bacterial toxins can exploit various mechanisms to
reach the cytosol and their substrate. Monomeric toxins such
as diphtheria toxin (DT) interact with endosomal membranes
through a hydrophobic domain, and translocation of the un-
folded enzymatic domain into the cytosol requires a pH gradi-
ent. The enzymatic components (edema and lethal factors) of
the respective binary edema and lethal toxins from Bacillus
anthracis are also translocated into the cytosol at low pH. This
is accomplished through a protein channel formed after hepta-
merization of binding components (protective antigen, PA) in
lipid rafts and subsequent internalization into endosomes via a
clathrin-dependent route [6,7].
In contrast, other toxins such as cholera toxin (CT), Shiga
toxin, and ricin are not translocated from endosomes into
the cytosol. Instead, these toxins are routed through retro-
grade transport via the Golgi apparatus into the endoplasmic
reticulum (ER), and ﬁnally the enzymatic domain is translo-
cated into the cytosol without acidiﬁcation. The exotoxin A
from Pseudomonas aeruginosa utilizes yet another route, as
the toxin is modiﬁed in an acidic compartment and subse-
quently translocated from another non-acidic organelle [8].
Although exotoxin A is transported to the Golgi apparatus
and ER, its eﬀects are impaired upon blocking the acidiﬁcation
of intracellular compartments [9–12].
To date, little is known about the entry and translocation
process of clostridial binary toxins. Iota and C2 toxins enterblished by Elsevier B.V. All rights reserved.
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cation step before translocation into the cytosol [13–15]. Since
the eﬀects of Iota toxin are not altered by chloroquine or
monensin, two alkalinizing agents that interfere with intracel-
lular traﬃcking of C2 toxin, it is likely that Iota toxin uses a
diﬀerent mechanism for entry and further intracellular trans-
port [16].
Our results reveal that internalization of Iota and C2 toxins
by a cell brings these proteins into an acidic endosomal com-
partment. In contrast to C2 toxin, a membrane potential is
necessary for translocating Iota toxin into the cytosol and to
our knowledge, this represents a genuinely novel process never
described for cellular intoxication by any bacterial toxin.2. Materials and methods
2.1. Materials
Amiloride, chloroquine (Chl), monensin (M), baﬁlomycin A1 (Baf),
brefeldin A (BFA), chlorpromazin (Chp), ﬁlipinIII, nigericin (Ni), con-
canamycin (Con), ammonium chloride, and nocodazole were from Sig-
ma.
2.2. Bacterial strains and toxin preparations
C. perfringens strains were grown in broth containing 30 g of Try-
pticase, 20 g of yeast extract, 5 g of glucose, and 0.5 g of cysteine-
HCl/l (pH 7.2) under anaerobic conditions. Ib and Ia components
were produced from C. perfringens strain 667 (lecithinase-, entero-
toxin-, beta-, epsilon-, and Iota-negative strain) harboring the recom-
binant plasmid pMRP384 or pMRP147, respectively [1,17]. In the
same way, C2-II and C2-I were produced from C. perfringens strain
667 harboring the recombinant plasmid pMRP885 or pMRP845,
respectively. Iota and C2 toxin components were puriﬁed as described
previously, and respectively a-chymotrypsin- or trypsin-activated Ib
or C2-II, were used in this study [1]. Fluorescent Ib and C2-II were
labeled with Cy3 (Amersham Biosciences) or Alexa555 (Molecular
Probes) according to the manufacturer’s recommendations. There
was no signiﬁcant loss of biological activity with ﬂuorescent Ib and
C2-II as discerned by cytotoxicity assays with the corresponding enzy-
matic components.
2.3. Cell cultures and assays with inhibitors
Vero cells were conﬂuently grown in Dulbecco’s Modiﬁed Eagle
Medium (DMEM) supplemented with 10% fetal calf serum (FCS) in
96-well plates for Iota and C2 toxin activity assays. Cells were pre-
treated for 30 min with the diﬀerent drugs at the indicated concentra-
tions in DMEM-10% FCS. For nocodazole experiments, cells were
incubated in DMEM-10% FCS containing 30 lM nocodazole on ice
for 30 min. The depolymerization of microtubules induced by noco-
dazole was monitored by immunoﬂuorescence with an anti-tubulin
monoclonal antibody (Amersham). Serial twofold dilutions of Iota
and C2 toxins containing equimolar concentrations of enzymatic and
binding components, starting at 107 M, were then added to cells
and incubated at 37 C for the indicated times. The cytopathic eﬀects
of Iota or C2 were assessed by actin depolymerization as described
below.
2.4. Measurement of ﬁlamentous actin
The amount of ﬁlamentous actin was measured using a modiﬁcation
of a previously described method [18,19]. After toxin treatment, cells
grown in 96-well plates were then washed with phosphate buﬀered sal-
ine (PBS) and ﬁxed with paraformaldehyde (3%) in PBS for 20 min at
room temperature. After two washes in PBS, the cells were stained
with 175 ng/ml rhodamine-labeled phalloidin (Molecular Probes) in
PBS containing 0.5% bovine serum albumin (BSA) and 0.5 mg/ml
saponin for 1 h at room temperature. After washing, rhodamine phal-
loidin was extracted with methanol (100 ll/well) overnight at 20 C,
and ﬂuorescence was measured with a spectrometer (Fluoroskan,
Labsystems) at 544 nm (kexcitation) and 590 nm (kemission). Results are
expressed as the percentage of ﬁlamentous actin content in cells trea-ted with toxins, versus untreated cells. An additional control for
actin polymerization included Latrunculin (Sigma), a sponge-derived
toxin that binds monomeric actin and prevents formation of actin
ﬁlaments.2.5. Acidic pulse experiments
Vero cell monolayers were incubated on ice for 30 min in DMEM-
25 mM HEPES-10% FCS containing 100 nM Baf and serial twofold
dilutions of 107 M Iota or C2 toxin. The cells were then washed three
times with cold PBS and incubated with 100 nM Baf for 10 min at
37 C in PBS at pH 4, 5, 6 or 7.2, as described previously [20]. Cells
were further incubated for 2 h in DMEM-10% FCS containing Baf,
and the actin ﬁlament content was determined as described above.
Controls corresponded to cells incubated with toxin in PBS, pH 7.2
that did not contain Baf.2.6. Diphtheria toxin (DT) and ricin toxicity assays
DT and ricin toxicity were assayed according to Lemichez et al. [21].
Brieﬂy, Vero cells were grown to conﬂuence in 24-well plates with
DMEM-10% FCS. Medium was then discarded and the cells incubated
with pre-warmed, leucine-free DMEM (Gibco). After 30 min at 37 C,
the diﬀerent drugs were added and further incubated with cells for
30 min at 37 C. DT or ricin (400 ng/ml) was added to the cells for
2 h at 37 C. The medium was replaced by leucine-free DMEM con-
taining 1 lCi [14C] leucine (Dupont NEN). After 1 h at 37 C, the cells
were washed three times with 1 ml of 10% trichloro-acetic acid. The
cells were solubilized in 200 ll of 0.2 M NaOH, and 50 ll were then
mixed with 4 ml of scintillation ﬂuid before recording the radioactivity.
Results are expressed as a percentage of inhibited protein synthesis rel-
ative to control preparations not incubated with DT or ricin.2.7. Immunoﬂuorescence
Non-conﬂuent Vero cells grown on cover slides were incubated on
ice for 30 min in DMEM-25 mM HEPES-10% FCS containing
107 M Ib-Cy3 or C2-II-Cy3. Following three washes with cold
DMEM, cells were incubated in prewarmed (37 C) DMEM-25 mM
HEPES-10% FCS with or without inhibitors for the indicated times.
Cells were washed with PBS, ﬁxed with 4% paraformaldehyde in
PBS for 20 min, washed with PBS, and free radicals were quenched
by incubation with 50 mM NH4Cl in PBS. Cells were then permeabi-
lized for 5 min with 0.2% Triton X-100 in PBS and incubated with
Texas Red-phalloidin. After washing in PBS, coverslips were mounted
in Mowiol (Calbiochem), and observed by confocal ﬂuorescence
microscopy.2.8. SDS–PAGE and Western blot analysis
Vero cells incubated with 107 M Ib with or without inhibitors as
indicated, were washed with cold DMEM-FCS and lysed in 20 mM
Tris–HCl, pH 7.5 containing 1% Triton X-100, 150 mM NaCl,
5 mM EDTA, 0.2 mg/ml BSA, and protease inhibitors (PMSF, leupep-
tin and pepstatin). Cell lysates were centrifuged (5 min at 800 · g) to
remove nuclei and the supernatant was brieﬂy sonicated on ice with
a microtip probe (10 s at 20%). Samples (100 lg total protein each)
were mixed with SDS Laemmli buﬀer without reducing agent or heat-
ing, and electrophoresed on a 4–15% acrylamide gradient gel (Ready
gel, BioRad). Separated proteins were transferred to nitrocellulose,
incubated with PBS containing 5% skim milk, and probed with anti-
Ib antibodies as previously described [22,23]. Estimation of percent
Ib oligomers versus Ib monomers, was done by densitometry scanning
using Image J (NIH).3. Results
3.1. Endocytosis of ﬂuorescent Iota and C2 toxin binding
components into Vero cells
We have shown that Ib can be transcytosed through CaCo-2
cells independently of Ia [24,25]. Thus, we monitored the entry
of Ib or C2-II into Vero cells using ﬂuorescently labeled
toxin components. Incubation of Vero cells with Ib-Cy3 or
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Fig. 1. Endocytosis of ﬂuorescent Ib and C2-II into Vero cells. Vero
cells were incubated on ice with 107 M Ib-Cy3 or C2-II-Cy3 for
30 min. After three washes with cold DMEM, cells were transferred to
DMEM prewarmed at 37 C. Typical staining of the cell periphery was
visualized after incubation of cells with Ib-Cy3 or C2-II-Cy3 at 4 C.
Transfer of cells to prewarmed medium induced rapid endocytosis of
ﬂuorescent Ib and C2-II into vesicular compartments ﬁrst located at
the cell periphery, and then in the perinuclear area over time.
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agreement with the binding of toxin components to a cell-sur-
face receptor [26,27] (Fig. 1). Upon transfer of cells from 4 C
to 37 C, Ib and C2-II molecules were rapidly internalized.
After 5 min at 37 C, most of the ﬂuorescent Ib and C2-II were
observed in intracellular vesicles namely localized near the
plasma membrane. After 10 min, endocytosed Ib and C2-II
were no longer associated with the cell membrane and ob-
served in vesicular structures scattered throughout the cytosol.
Over time, intracellular compartments stained with Iota and
C2 toxin binding components were accumulated in the perinu-
clear area, whereas staining of peripheral compartments
clearly disappeared (Fig. 1).3.2. Cytosolic entry of Iota and C2 toxins requires an acidic
pulse
Historically, the study of toxin transport has allowed the
identiﬁcation of several novel intracellular pathways [8]. For
instance, DT is delivered into the cytosol from early endo-
somes following acidiﬁcation of endocytic vesicles [9]. In con-
trast, Shiga toxin and ricin use a more complex retrograde
route to reach the Golgi apparatus and ER, but these toxins
do not require acidiﬁcation for translocation into the cytosol
[28,29]. Iota and C2 toxins do require an acidic pH for cyto-
solic entry from endosomes, but the pH requirements for each
are evidently diﬀerent [13–17,30]. Here, we studied the cyto-
toxic eﬀects of Iota and C2 toxins following their cellular up-
take by monitoring the depolymerization of actin ﬁlaments
induced by intracellular enzymatic components. We used a
quantitative assay that measures the amount of ﬁlamentous
actin in order to more precisely examine the potential diﬀerences
existing between cytosolic entry of C2 and Iota toxins, that in-
cludes: (1) pH requirements for translocation of intracellular
biologically active Ia and C2-I; and (2) diﬀerential protective
eﬀects on cells of chloroquine and monensin that were reported
previously [16,30]. A Latrunculin control for actin polymeriza-
tion was used to further conﬁrm the C2 and Iota toxin result
from these experiments. There was a similar dose–response
curve evident for these toxins on Vero cells (data not shown).
The alkalinizing agents chloroquine and monensin are,
respectively a proton trap and an ionophore for monovalent
cations that reverse the proton gradient through the endo-
somal membrane [31]. These drugs, when used at concentra-
tions that block the activity of DT (Fig. 2C), eﬃciently
prevented actin depolymerization induced by C2 (Fig. 2B),
but not Iota, toxin (Fig. 2A). Even a 20-fold higher concentra-
tion of monensin (100 lM) did no prevent Iota toxin-induced
cytotoxicity (data not shown). Another ionophore, nigericin,
also inhibited the cytoskeletal perturbations of C2 toxin in
Vero cells, but again there was no eﬀect on Iota toxin
(Fig. 2A and B).
In contrast to the ionophore drugs, baﬁlomycin A1 (Baf) or
concanamycin prevent endosomal acidiﬁcation by selective
inhibition of the vacuolar-ATPase [32], and both were as eﬃ-
cient at blocking the eﬀects of Iota or C2 toxin on actin
(Fig. 2A and B). It is likely that the diﬀerential sensitivity of
Iota and C2 toxins towards these drugs reﬂects diﬀerences in
translocation and/or intracellular pathways used by these re-
lated toxins.
Since Iota toxin activity was more resistant to the inhibitors
of endosomal acidiﬁcation than C2 toxin, quantitative
measurement of ﬁlamentous actin was performed with acidic
pulses in Vero cells pretreated with Baf and subsequently
incubated with Iota or C2 toxin. Baf inhibits the normal entry
pathway of toxin from acidiﬁed endosomes. However, a brief
exposure of cells to a low pHmimics intravesicular acidiﬁcation
and thus permits translocation of cell-bound toxin directly into
the cytosol through the plasma membrane [9].
Figs. 3A and B show that the normally protective eﬀects of
Baf on actin depolymerization induced by Iota or C2 toxin
were overridden when the cells were bathed for 10 min in a
buﬀer at pH 6 or less, in agreement with previous work
[14,15,33]. We found that a pH of 4 was more eﬃcient than
a higher pH for reversing the inhibitory eﬀect of Baf on C2
and Iota toxin (Fig. 3A and B), which is similar to the pH
value (below pH 5.3) found for the direct entry of DT from
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Fig. 2. Eﬀects of pharmacological drugs on Iota and C2 toxin-induced actin depolymerization in Vero cells. Actin ﬁlament content was measured in
Vero cells pretreated either with chloroquine (0.1 mM; Chq), monensin (5 lM; M), baﬁlomycin A1 (100 nM; Baf), brefeldin A (2.5 lg/ml; BFA),
nigericin (10 lM; Ni), concanamycin (20 nM; Con), or media alone (Ctrl) and exposed to serial two-fold dilutions of Iota toxin (A) or C2 toxin (B).
Filamentous actin content was measured as described in Section 2. Controls for the activity of chloroquine (0.1 mM), monensin (5 lM), baﬁlomycin
A1 (700 nM), and brefeldin A (2.5 lg/ml) were DT (5 nM) (C) and ricin (5 nM) (D) as measured by inhibition of protein synthesis in Vero cells. Data
are means ± S.D. (n = 5).
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Fig. 3. Requirement of an acidic pulse for Iota and C2 toxin entry into Vero cells. For acidic pulse experiments, Vero cell monolayers were washed
with cold DMEM-25 mM HEPES-10% FCS and incubated on ice for 30 min in the same medium containing 100 nM Baf plus serial twofold
dilutions of either Iota (A) or C2 (B) toxin. The cells were then washed three times to remove unbound toxin with cold PBS, and incubated in PBS
containing Baf at a diﬀerent pH for 10 min at 37 C. Cells were brieﬂy washed with cold PBS and incubated for an additional 2 h at 37 C in DMEM-
1% FCS containing Baf to prevent toxin entry by its normal route. Controls of toxin activity (j) were performed in cells treated with toxin, but not
Baf, at pH 7.2. Data are means ± S.D. (n = 5).
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clude that both toxins require the same low pH for optimal
translocation of the enzymatic component, and in fact Blo¨ckeret al. [15] discovered that Iota toxin requires a lower pH than
C2 for entry directly from the cell surface into the cytosol, thus
circumventing the normal endosomal pathway.
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Fig. 4. Iota and C2 toxins use kinetically diﬀerent traﬃcking pathways. (A) Vero cells were treated either with 107 M Iota (j) or C2 (h) toxin (time
point ‘‘0’’), and Baf (100 nM) was added at diﬀerent time intervals after toxin incubation. The cells were further incubated at 37 C for 2 h after the
last addition of Baf, and F-actin content was assayed. Baf prevented the loss of actin ﬁlaments during a longer time period in cells incubated with Iota
toxin versus C2 toxin. As a control (B), actin ﬁlament content was measured in Vero cells following Iota or C2 toxin entry triggered from the plasma
membrane by an acidic pulse, thus bypassing the normal endocytic process blocked by Baf. Cells were pretreated with Baf (100 nM) for 30 min at
37 C and then incubated with Iota or C2 toxin (107 M) in the presence of Baf for an additional 30 min at 37 C. After washing, the cells were
incubated with PBS (pH 4) for 10 min, and then in DMEM containing Baf. At the indicated times, actin ﬁlament content was measured
spectrophotometrically via rhodamine-labeled phalloidin. These latter results revealed that Iota and C2 toxins possess quite similar kinetics and
eﬀects upon Vero cells when they enter the cytosol directly from the cell surface. Data are means ± S.D. (n = 5).
M. Gibert et al. / FEBS Letters 581 (2007) 1287–1296 12913.3. C2 and Iota toxins use kinetically diﬀerent traﬃcking
pathways
To further explore the link between acid-dependent entry
into the cytosol and subsequent biological activity of these tox-
ins, the following experiment was performed. The depolymer-
ization of actin ﬁlaments was measured in Vero cells incubated
with Iota or C2 toxin, followed by the addition of Baf at sub-
sequent time intervals (Fig. 4A). When Baf was added 15 min
or later after C2 toxin, there was no protection against actin
depolymerization induced by the toxin. However, the time per-
iod required for the same protective eﬀect by Baf was longer
(35–40 min) for Iota toxin. These results indicated that sur-
face binding, endocytosis, intracellular traﬃcking and biologi-
cal activity upon cells (i.e. actin depolymerization) of C2 toxin
occurred overall more rapidly than that for Iota toxin.
Additionally, we have veriﬁed that the time required for
translocation and then intracellular activity of Ia and C2-I
are virtually identical (Fig. 4B). For that, Vero cells pretreated
with Baf (100 nM) were incubated with Iota or C2 toxin, which
thereby could not enter cells by their normal endocytic path-
way. Toxin entry directly from the plasma membrane into
the cytosol was triggered by an acidic pulse (pH 4, 10 min),
and the kinetics of actin ﬁlament depolymerization were mon-
itored over time (Fig. 4B).
Overall, these collective results strongly suggested that the
endocytic process is shorter for C2 toxin versus Iota toxin. It
is therefore possible that C2 toxin either uses a more eﬃcient
mechanism of translocation at low pH than Iota toxin, or each
toxin can follow a distinct endocytic pathway to reach diﬀerent
intracellular compartments with an appropriate pH for trans-
location.
In addition to investigating the pH eﬀects upon cytosolic en-
try of Iota and C2 toxins, two other drugs were used for protec-
tion studies in the quantitative actin assay. Brefeldin A (BFA),
a Golgi disrupter and inhibitor of CT, ricin, and Shiga toxin
transport, as well as nocodazole, a drug that disrupts tubulin
ﬁlaments and blocks early to late endosomal traﬃcking, were
both tested in Vero cells. Neither BFA nor nocodazole
prevented actin modiﬁcation by Iota or C2 toxin (Fig. 2A–
D). These results are similar to those previously reported byBlo¨cker et al. [15] when using a cytotoxicity test. However, in
contrast to Iota toxin, C2 toxin and DT, BFA did block ricin
eﬀects on cells (Fig. 2D) [34].
3.4. Both a proton and vesicle transmembrane potential are
required for translocating Iota toxin
It was intriguing that potent inhibitors of vesicle acidiﬁcation,
such as monensin, did not prevent the cytosolic entry of Iota
toxin. Recently, it was found that the ﬁbroblast growth factor-
1 (FGF-1) is translocated from vesicles possessing vacuolar
proton pumps by means of a vesicular membrane potential. In
this case, the translocation of FGF-1 is blocked by Baf, which
presumably prevents both the pH and transmembrane potential
gradients [35], however, monensin or lysomotropic agents such
as ammonium chloride and chloroquine that only prevent
endosomal acidiﬁcation are ineﬀective. Translocation of FGF-
1 is also prevented by the combination of monensin and valino-
mycin, which are respectively a neutral monovalent cation
exchanger and electrogenic K+ ionophore that abolish the
transmembrane potential. Therefore, intravesicular H+ are
exchanged for K+ by monensin, while valinomycin dissipates
K+ into the cytosol and thus abolishes the membrane potential
[35]. When we tested a combination of monensin and valinomy-
cinwith various concentrations of Iota toxin, an inhibitory eﬀect
was observed (Fig. 5A).
The inhibition of FGF-1 translocation by Baf is overcome
by monensin, due to activated Na+/K+-ATPase that exchanges
K+ for Na+ and restores the membrane potential required for
FGF-1 transport across membranes [35]. When using a low
concentration of Baf (10 nM) that partially inhibited the eﬀects
of Iota toxin, addition of monensin blocked the depolymeriza-
tion of actin induced by Iota in a concentration-dependent
manner (Fig. 5B). A possible interpretation of these results
was that vesicles where translocation of Iota toxin had oc-
curred, were either devoid of, or had non-functional forms
of, Na+/K+-ATPase. Low amounts of Baf were suﬃcient to in-
hibit the membrane potential, which was not restored by
adding monensin and thus reactivating Na+/K+-ATPase.
Additionally, the pH gradient was totally abolished by Baf
and monensin. We have checked whether inhibition of the
Baf Baf + M Val Val + M
Ib-Cy3
C2-II-Cy3
Fig. 6. Inhibition of endosome acidiﬁcation and membrane potential does not impair endocytosis of Ib or C2-II. Vero cells were pretreated with
100 nM baﬁlomycin A1 (Baf), 100 nM Baf + 1 lM monensin (M), 20 lM valinomycin (Val), or 20 lM Val + 1 lM M. Binding of ﬂuorescent Ib or
C2-II was done at 4 C, as previously described in Fig. 1, and cells were then transferred to prewarmed DMEM medium at 37 C for 15 min.
Endosome labeling induced by Ib-Cy3 or C2-II-Cy3 was not impaired by the drugs as compared to controls in Fig. 1.
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Fig. 5. Iota toxin requires a gradient of membrane potential to elicit its cytopathic eﬀect. (A) Vero cells were pretreated with valinomycin (Val;
20 lM) and monensin (M; 1 lM), then incubated with Iota toxin. A combination of Val and M delayed the cytopathic eﬀects induced by Iota toxin
relative to cells without drugs (ctrl), or those pretreated with Val (20 lM) or M (1 lM) alone (not shown). (B) Cells were pretreated with Baf (10 nM)
alone or in association with 5, 1, or 0.1 lMmonensin (M) for 30 min at 37 C, and then exposed to Iota toxin. Cells were incubated for an additional
2 h and the actin ﬁlament content was assayed. The combination of M with a sub inhibitory concentration of Baf prevented the Iota cytopathic eﬀects
in a dose-dependent manner. Data are means ± S.D. (n = 3).
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pair endocytosis of the binding components. As shown in
Fig. 6, either Baf and valinomycin, alone or in combination
with monensin at concentrations that inhibit cytotoxicity, did
not impair the uptake of ﬂuorescent Ib or C2-II into intracel-
lular vesicles after 15 min at 37 C.
Overall, these experiments suggested that the translocation
of Iota toxin required both a proton and membrane potential
gradient, and this process occurred from endocytic carrier ves-
icles and late endosomes that possess a vacuolar-, but not a
Na+/K+-ATPase [36].
3.5. Formation of Ib functional channels is not impaired by
inhibitors of endosome acidiﬁcation and transmembrane
potential
A prerequisite step in Iota or C2 intoxication is the forma-
tion of functional Ib or C2-II pores through the endosomal
membrane to enable passage of the corresponding enzymatic
component into the cytosol [17,33]. For PA, which shares asigniﬁcant amino acid sequence homology with Ib [37],
functional pores occur at neutral or low pH and correlate
with formation of SDS-resistant oligomers [38–40]. Further
studies show that SDS-resistant PA heptamers are mainly
formed in early endosomes [41]. However, formation of
SDS-resistant Ib oligomers on Vero cells is not inﬂuenced by
pH ranging from 4 to 9 [23]. Therefore, we investigated
whether inhibitors of endosome acidiﬁcation or transmem-
brane potential impair formation of SDS-resistant Ib oligo-
mers in Vero cells.
As previously described [23], Ib incubated with Vero cells at
4 C did not signiﬁcantly form oligomers, whereas incubation
at 37 C induced a large proportion of SDS-resistant Ib oligo-
mers dependent upon lipid rafts [22]. Baf, valinomycin, or
combinations with monensin did not signiﬁcantly impair for-
mation of SDS-resistant Ib oligomers on Vero cells, at least
at the drug concentrations used for these studies as shown
by SDS-gel/Western blots and densitometry-based estimation
of the oligomers rate (Fig. 7).
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Fig. 7. Inhibition of endosome acidiﬁcation and membrane potential
does not impair Ib-dependent SDS-resistant oligomer formation. Vero
cells were incubated in DMEM-FCS without (Ctrl) or with 20 lM
valinomycin (Val), 20 lM valinomycin + 1 lM monensin (Val + M),
100 nM baﬁlomycin A1 (Baf), or 100 nM baﬁlomycin A1 + 1 lM
monensin (Baf + M), for 30 min at 37 C. Ib (107 M) was added to
the culture medium with cells and incubated for an additional 10 min
at 37 C, except for control cells (no drug added) kept on ice prior, and
after, the addition of Ib. Cells were lysed and 100 lg total protein per
sample mixed with SDS-Laemmli buﬀer without reducing agent or
heat. Electrophoresis was done on a 4–15% polyacrylamide gel,
separated proteins were then transferred to nitrocellulose, and ﬁnally
probed with anti-Ib antibodies. SDS-resistant oligomers were formed
at 37 C, but not 4 C, and this large molecular weight complex was
not impaired by inhibitors of endosome acidiﬁcation and membrane
potential. Quantitative percentages of Ib oligomer versus Ib monomer
were determined with Image J (NIH) densitometry scanning from three
independent experiments.
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Binding of Iota and C2 toxins to currently unidentiﬁed cell-
surface receptors, is followed by their endocytosis into a vesic-
ular/endosomal compartment from which they must escape to
reach the cytosol and modify monomeric actin. Drugs that in-
hibit endosomal acidiﬁcation protected cells from intoxication
by C2 toxin as well as DT (Fig. 2B and C), and the anthrax
toxins, as previously shown [13,14,16,30,42,43]. In contrast,
Iota toxin diﬀers from C2 and anthrax toxins since chloro-
quine, monensin, nigericin, or ammonium chloride did not in-
hibit its activity (Fig. 2A). C. spiroforme toxin, which is very
highly related to Iota toxin, is also cytotoxic in the presence
of chloroquine and ammonium chloride [44,45]. However, Iota
and C2 toxins were equivalently blocked by two diﬀerent vac-
uolar-ATPase inhibitors, Baf or concanamycin, and both tox-
ins were internalized from the cell surface into the cytosol
following an acidic pulse of Baf-treated cells (Fig. 3A and
B), thus agreeing with previous data [14,15]. A pH gradient be-
tween the endosomes and cytosol is probably required for
translocating Ia and C2-I, just as described for anthrax edema
and lethal factors. A lower pH is seemingly required for trans-
locating Iota, versus C2, toxin into the cytosol [15], and this
perhaps could explain how weak bases, such as chloroquine,
ineﬃciently protected Vero cells from Iota toxin activity. How-
ever, the inhibitory eﬀects of chloroquine have been related not
only to preventing endosomal acidiﬁcation, but also binding ofthis drug to the vestibule area of the C2-II pore, which subse-
quently blocks the channel required for delivering enzymatic
component into the cytosol [30,46,47]. Both chloroquine and
tetraalkylammonium ions bind with high aﬃnity to C2-II
and PA, thus preventing toxicity, whereas these compounds
bind with lower aﬃnity to Ib and thus do not impair its biolog-
ical activity [17,30,47,48]. Iota toxin eﬀects were not prevented
by monensin, which is an electroneutral exchanger of monova-
lent cations that only abolishes the pH gradient through endo-
somal membranes. Furthermore, inhibitors of endosomal
acidiﬁcation or membrane potential did not impair the assem-
bly of SDS-resistant Ib oligomers in Vero cells which is a pre-
requisite step towards forming functional channels. It is
noteworthy that Ib oligomers rapidly form in less than 1 min
at 37 C on Vero cells [23], and that Baf added subsequent
to Iota toxin inhibited the latter’s eﬀect upon Vero cells
(Fig. 4). This indicates that pH and/or membrane potential
gradients between the endosomal compartment and cytosol
are critically required for translocating enzymatic components
of clostridial binary toxins. The ﬁndings that: (1) Iota toxicity
was not inhibited by monensin alone; (2) a combination of
monensin and valinomycin partially inhibited the toxin; and
(3) monensin synergized the inhibitory eﬀects of Baf, alto-
gether strongly suggest that Iota toxin requires both proton
and membrane potential gradients for Ia translocation into
the cytosol, in a similar mechanism that was recently discov-
ered for the eukaryotic cell growth factor, FGF-1 [35]. This
current study is the ﬁrst to report that a membrane potential
gradient can also facilitate translocation of any bacterial toxin
into the cytosol, and perhaps further investigation with other
bacterial toxins may reveal similar exploitation of this inherent
eukaryotic system by pathogens.
The eﬀects of Iota and C2 toxin were not prevented by BFA
and nocodazole. BFA inhibits the transport of ricin and Shiga
toxins from endosomes to the Golgi apparatus [49], and noco-
dazole perturbs transport between early and late endosomes as
well as movement from the Golgi apparatus to the ER [50].
These results are in agreement with a recent report [15], and
an earlier ﬁnding [45] that there was no eﬀect of C. spiroforme
toxin when cells were co-incubated at 15 C. This temperature
prevents protein traﬃcking from endosomes to the trans Golgi
network.
Two main types of intracellular routes for bacterial toxins
are evident for translocating enzymatic domains into the cyto-
sol. These routes include a long retrograde pathway from the
plasma membrane to the ER through the Golgi apparatus
(i.e. CT, Pseudomonas exotoxin A, ricin, and Shiga toxin),
and a shorter route involving the endosomes (i.e. DT) [9].
Therefore, the results with pharmacological drugs and analysis
of endocytosis of ﬂuorescently labeled toxins indicate that Iota
and C2 toxins use a short pathway that involves early, or pos-
sibly late, endosomes. The experiment where Baf was added at
diﬀerent times after Iota or C2 toxin (Fig. 4A) suggests that the
endocytic process is shorter for C2, than for Iota toxin. C2
toxin could use a more eﬃcient translocation mechanism than
Iota, or each toxin could follow a diﬀerent endocytic pathway
after internalization from the plasma membrane.
In addition to the known eﬀect of Baf as a speciﬁc blocker of
vacuolar-ATPase and endosomal acidiﬁcation, other eﬀects of
this drug include preventing the formation of intermediate ves-
icles (endocytic carrier vesicles, ECVs) from early endosomes
[50,51], as well as inhibiting transport from late endosomes
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toxin eﬀects, could therefore act by preventing endosomal
acidiﬁcation required for the translocation step as well as block
endocytic transport of these toxins. It has been reported that in
HeLa cells, Baf prevents the transport of rhinoviruses from
early endosomes to ECVs, whereas nocodazole inhibits further
traﬃcking from ECVs to late endosomes [54]. As shown with
ﬂuorescent Ib or C2-II, Baf as well as valinomycin, when given
either alone or in combination with monensin, did not impair
entry of these binding components from the plasma membrane
to endocytic compartments. However, it cannot be ruled out
that Baf inﬂuences traﬃcking within intracellular compart-
ments. Since it takes more time for Iota toxin delivery into
early endosomes versus C2 toxin (Fig. 4), it is likely that Iota
toxin is translocated from ECVs because its cytopathic eﬀects
were blocked by Baf, but not nocodazole. ECVs are more
acidic compartments (pH < 5.6) than early endosomes (pH
6.5) [54,55], and this pH diﬀerence could account for the
inability of inhibitors against endosomal acidiﬁcation to aﬀect
Iota cytotoxicity, in contrast to that of C2. The additive inhib-
itory eﬀects of Baf and monensin also support the paradigm
that Iota toxin translocates from vesicles, such as ECVs, which
lack Na+/K+-ATPase [36].
Results from this study, as well as those from others, now
provide a clearer picture for internalization and intracellular
transport of Iota and C2 toxins (Fig. 8). Binding componentsIbIa
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Fig. 8. A model for the endocytosis and translocation of Iota and C2 toxi
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oligomerize into heptameric ring structures, form transmem-
brane channels, and dock with an enzymatic component(s)
[14,15,26]. After endocytosis, the catalytic components escape
the endosomal network to access the pool of cytosolic actin.
While C2 toxin delivers its enzymatic component into the cyto-
sol from early endosomes, Iota toxin further migrates until it
reaches ECVs. Enzymatic components probably pass through
the channel formed by oligomeric binding components follow-
ing a pH gradient [30], and in addition a membrane potential
gradient is uniquely required for translocating Iota toxin. The
necessity of a membrane potential gradient for Ia translocation
into the cytosol is a novel concept for any bacterial toxin, and
it is likely that further studies will reveal similar mechanisms
with other intracellular-acting toxins. This certainly does not
preclude that other cytosolic factors are not also involved in
translocating enzymatic toxin components into the cytosol,
as shown recently for DT [56]. Indeed, heat shock protein 90
(Hsp-90) reportedly facilitates transport of C2-I and Ia, as well
as FGF-1, across the endosomal membrane [57–59].
In summary, our study combines cell biology and drug-
based experiments to provide a rather unique way of charac-
terizing the traﬃcking-related molecular machinery involved
in the onset of Iota and C2 cytotoxicity. While translocation
of both toxins requires a low pH, only Iota toxin additionally
employs a membrane potential, that also facilitates FGF-1Late
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lization than C2 toxin, probably delivers its enzymatic component into
M. Gibert et al. / FEBS Letters 581 (2007) 1287–1296 1295transport across endosomal membranes into the cytosol [35].
Studies focused upon these clostridial toxins indeed provide
a further understanding of eukaryotic methods employed for
transporting molecules across biological membranes, and such
knowledge should facilitate more rational designs of delivery
systems for therapeutic purposes.
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